/
/
/

Suven Life Sciences Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)304.00
Volume (₹)5.28 L
High (₹)308.85
Upper Circuit360.30
Low (₹)298.10
Lower Circuit240.20
Prev Close300.25
52W High (₹)403.35
Price303.55
52W Low (₹)124.11

Share Market Cap & Key Ratios Overview

M.Cap (₹)8471.23 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.00
Price to Book8.07
Book Value16.46
EPS (TTM)-12.47
Face Value1.00
ROE (%)-101.81

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
SUVENNSE
LTP
1W Low
1W High
Market cap (₹)
1758.8-1.2 (-0.07%)
1725.50
1778
4,22,427Cr
9144.5-195.5 (-2.09%)
8937.50
9431.50
2,39,982Cr
4558.9-98 (-2.10%)
4550.40
4682
1,75,196Cr
1123+5.5 (0.49%)
1107.30
1150.90
1,13,790Cr
2060.1+23.5 (1.15%)
2007.80
2086
1,09,143Cr
1325.1+24.1 (1.85%)
1300.20
1337.50
1,07,746Cr
1233+36 (3.01%)
1196.90
1250.70
1,01,894Cr
2275.5-93 (-3.93%)
2268.70
2426.80
97,264Cr
1666.9-26.1 (-1.54%)
1647.10
1715
96,376Cr
1961.6+5.1 (0.26%)
1925.70
1990.90
89,592Cr
303.55+20.8 (7.36%)
276.50
311
8,471Cr

Key Highlights of Suven Life Sciences Ltd Balance Sheet

Suven Life Sciences Ltd balance sheet discloses shareholders' funds of ₹26.37Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹26.37Cr, and the reserves and surplus of the company is ₹1319.77Cr.

The company has its non-current liabilities with total liabilities of ₹1531.06Cr as of 2026-03-31.

The current liabilities are ₹13.63Cr as of 2026-03-31. At the same time, current assets are ₹540.71Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹912.85Cr and tangible assets of ₹73Cr, provided in the Suven Life Sciences Ltd financial statements.